Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Wasif Saif

Showing results (131-140 of 473) with videos related to

Pageof 48
Sort By:
JOP : Journal of the Pancreas|May 13, 2008
Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapySoonmo Peter Kang, Muhammad Wasif Saif
Resident and Staff Physician|November 12, 2021
Hematological Complications of Acute Pancreatitis: A ReviewMuhammad Wasif Saif, Carmen J Allegra
Cancer Chemotherapy and Pharmacology|June 10, 2016
Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiencyMuhammad Wasif Saif, Robert B Diasio
JOP : Journal of the Pancreas|July 13, 2013
Utilizing endoscopic ultrasound-guided fine needle aspiration in identifying molecular targets for pancreatic cancerOnyekachi Henry Ogbonna, Muhammad Wasif Saif
JOP : Journal of the Pancreas|November 19, 2019
Pancreatic Enzyme Replacement Therapy: A Concise ReviewGregory T Brennan, Muhammad Wasif Saif
JOP : Journal of the Pancreas|March 13, 2014
Updates on the use of neoadjuvant therapy in borderline resectable pancreatic cancerNamrata Sonia Chandhok, Muhammad Wasif Saif
The Journal of Supportive Oncology|August 22, 2007
Identifying and treating fluoropyrimidine-associated hand-and-foot syndrome in white and non-white patientsMuhammad Wasif Saif, Aymen A Elfiky
The Journal of Supportive Oncology|November 21, 2007
Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and managementSoonmo Peter Kang, Muhammad Wasif Saif
JOP : Journal of the Pancreas|March 10, 2011
Three-drug combination regimen in pancreatic cancer treatment: are we there yet?Soonmo Peter Kang, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 9, 2011
Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Paul E Oberstein, Muhammad Wasif Saif
Pageof 48

Showing results (131-140 of 473) with videos related to

Sort By:
Pageof 48
JOP : Journal of the Pancreas|May 13, 2008
Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapySoonmo Peter Kang, Muhammad Wasif Saif
Resident and Staff Physician|November 12, 2021
Hematological Complications of Acute Pancreatitis: A ReviewMuhammad Wasif Saif, Carmen J Allegra
Cancer Chemotherapy and Pharmacology|June 10, 2016
Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiencyMuhammad Wasif Saif, Robert B Diasio
JOP : Journal of the Pancreas|July 13, 2013
Utilizing endoscopic ultrasound-guided fine needle aspiration in identifying molecular targets for pancreatic cancerOnyekachi Henry Ogbonna, Muhammad Wasif Saif
JOP : Journal of the Pancreas|November 19, 2019
Pancreatic Enzyme Replacement Therapy: A Concise ReviewGregory T Brennan, Muhammad Wasif Saif
JOP : Journal of the Pancreas|March 13, 2014
Updates on the use of neoadjuvant therapy in borderline resectable pancreatic cancerNamrata Sonia Chandhok, Muhammad Wasif Saif
The Journal of Supportive Oncology|August 22, 2007
Identifying and treating fluoropyrimidine-associated hand-and-foot syndrome in white and non-white patientsMuhammad Wasif Saif, Aymen A Elfiky
The Journal of Supportive Oncology|November 21, 2007
Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and managementSoonmo Peter Kang, Muhammad Wasif Saif
JOP : Journal of the Pancreas|March 10, 2011
Three-drug combination regimen in pancreatic cancer treatment: are we there yet?Soonmo Peter Kang, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 9, 2011
Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Paul E Oberstein, Muhammad Wasif Saif
Pageof 48